NCDActive
Oxygen Treatment of Inner Ear/Carbon Therapy
NCD43
Effective: August 1, 1978
Updated: December 31, 2025
Policy Summary
Oxygen (95%) with carbon dioxide (5%) inhalation therapy for inner ear disorders, including endolymphatic hydrops and fluctuating hearing loss, is considered not reasonable and necessary and is not covered. The policy specifies no covered indications, documentation requirements, or frequency allowances for this therapy.
Coverage Criteria Preview
Key requirements from the full policy
"Oxygen (95%) and carbon dioxide (5%) inhalation therapy for inner ear disease (e."
Sign up to see full coverage criteria, indications, and limitations.
Covered Medical Codes